Total
0
Shares
Cellmid (ASX:CDY) - Chief Executive, Maria Halasz - The Market Herald
Chief Executive, Maria Halasz
Source: SMH
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Cellmid (CDY) has received the first orders for its skincare products from Hong Kong-based distributor Ourui Health Management
  • The first order is for 66,000 bottles of Jo-Ju shampoo, which will be delivered in bulk and packaged in China
  • Cellmid has also received an order for 18,672 bottles of fully finished Jo-Ju lotions with import permit
  • These orders have a combined revenue value of $530,000, and are scheduled for delivery in February and April 2021
  • Cellmid is up 9.52 per cent and trading at $0.12 per share

Cellmid (CDY) has received the first order for its skincare products from Hong Kong-based distributor Ourui Health Management.

On December 14, 2020, Cellmid’s subsidiaries Advangen Limited and Advangen Inc signed an exclusive ten-year master distribution agreement with OHM. Under the arrangement, OGM agreed to sell Cellmid’s Jo-Ju and Lexilis anti-aging and skincare products in China. 

The first order the company has received is for 66,000 bottles of Jo-Ju shampoo, which will be packaged in China, at OHM’s costs. This shipment will be delivered in bulk, since no import permit has been received for the fully finished shampoo yet.

Additionally, Cellmid has received an order for 18,672 bottles of fully finished Jo-Ju lotions, with an import permit. 

In total, the two orders which the company has received have a combined revenue value of $530,000, which is paid before and will accrue on delivery. Cellmid intends to deliver these orders in February and April of 2021.

Per the terms of the Cellmid’s contract with OHM, a 500,000-unit order is required within the first twelve months of the agreement. 

It’s expected that the company will receive roughly half of the first-year orders in October 2021. This bulk-buy in October will come ahead of the biggest shopping day in China’s retail calendar, Singles Day, which falls on November 11.  

After this, minimum purchase orders under the distribution agreement will increase to one million units in the second year, with a double-digit percentage increase every year afterwards.

Cellmid is up 9.52 per cent and trading at $0.12 per share at 11:33 am AEDT.

CDY by the numbers
More From The Market Herald
Patrys (ASX:PAB) selects stable cell line for PAT-DX1 production

" AFT Pharmaceuticals (ASX:AFP) signs exclusive Maxigesic IV licensing agreement

AFT Pharmaceuticals has signed an exclusive Maxigesic IV licensing agreement for eight new European markets.
Althea Group (ASX:AGH) - CEO, Joshua Fegan - The Market Herald

" Althea Group’s (ASX:AGH) subsidiary gets A$137K order to make cannabis concentrates

Althea Group’s (AGH) subsidiary, Peak Processing Solutions, has received an C$134,000 (roughly A$137,216) purchase order from Peace Naturals Project.
Immutep (ASX:IMM) - CEO, Marc Voigt (left) - The Market Herald

" Immutep (ASX:IMM) expands TACTI-002 study

Immutep (IMM) has expanded Part B of its TACTI-002 phase two trial, following a recommendation from the data monitoring committee.
ImpediMed (ASX:IPD) - CEO, Rick Carreon - The Market Herald

" ImpediMed (ASX:IPD) completes 200,000 patient tests

ImpediMed  (IPD) says it has reached a milestone 200,000 patient tests for SOZO testing.